Literature DB >> 16029060

Novel advances in drug delivery to brain cancer.

Maciej S Lesniak1.   

Abstract

The therapy of brain tumors has been limited by a lack of effective methods of drug delivery to the brain. Systemic administration is often associated with toxic side effects and ultimately fails to achieve therapeutic concentrations within a tumor. An attractive strategy that has gained importance in brain tumor therapy has relied on local and controlled delivery of chemotherapeutic agents by biodegradable polymers. This technique allows direct exposure of tumor cells to a therapeutic agent for a prolonged period of time and has been shown to prolong the survival of patients with malignant brain tumors. The use of polymers for local drug delivery greatly expands the spectrum of drugs available for the treatment of malignant brain tumors. This review discusses the rationale for local drug delivery, describes the development of currently available polymer-based therapeutic agents, and highlights examples of promising non-polymer based drug delivery methods for use in the treatment of malignant brain tumors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16029060     DOI: 10.1177/153303460500400409

Source DB:  PubMed          Journal:  Technol Cancer Res Treat        ISSN: 1533-0338


  8 in total

Review 1.  Getting into the brain: approaches to enhance brain drug delivery.

Authors:  Mayur M Patel; Bhoomika R Goyal; Shraddha V Bhadada; Jay S Bhatt; Avani F Amin
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

2.  A comparative study of neural and mesenchymal stem cell-based carriers for oncolytic adenovirus in a model of malignant glioma.

Authors:  Atique U Ahmed; Matthew A Tyler; Bart Thaci; Nikita G Alexiades; Yu Han; Ilya V Ulasov; Maciej S Lesniak
Journal:  Mol Pharm       Date:  2011-06-30       Impact factor: 4.939

Review 3.  Delivery of small-interfering RNA (siRNA) to the brain.

Authors:  Saroj P Mathupala
Journal:  Expert Opin Ther Pat       Date:  2009-02       Impact factor: 6.674

4.  Local controlled delivery of anti-neoplastic RNAse to the brain.

Authors:  Joram Slager; Betty Tyler; Ariella Shikanov; Abraham J Domb; Kuslima Shogen; David Sidransky; Henry Brem
Journal:  Pharm Res       Date:  2009-05-05       Impact factor: 4.200

Review 5.  MicroRNA and brain tumors: a cause and a cure?

Authors:  Saroj P Mathupala; Sandeep Mittal; Murali Guthikonda; Andrew E Sloan
Journal:  DNA Cell Biol       Date:  2007-05       Impact factor: 3.311

Review 6.  The potential of polymeric micelles in the context of glioblastoma therapy.

Authors:  Ramin A Morshed; Yu Cheng; Brenda Auffinger; Michelle L Wegscheid; Maciej S Lesniak
Journal:  Front Pharmacol       Date:  2013-12-30       Impact factor: 5.810

7.  Evaluation of adenovirus capsid labeling versus transgene expression.

Authors:  Jing Li; Aiman Fatima; Svetlana Komarova; Hideyo Ugai; Priyanka Uprety; Justin C Roth; Minghui Wang; Robert A Oster; David T Curiel; Qiana L Matthews
Journal:  Virol J       Date:  2010-01-26       Impact factor: 4.099

8.  Combination of adenoviral virotherapy and temozolomide chemotherapy eradicates malignant glioma through autophagic and apoptotic cell death in vivo.

Authors:  I V Ulasov; A M Sonabend; S Nandi; A Khramtsov; Y Han; M S Lesniak
Journal:  Br J Cancer       Date:  2009-03-10       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.